Clinical Trial: Efficacy and Safety Study of Moxidectin in Adults With Scabies
Study Status: Completed
Recruit Status: RECRUITING
Condition: Scabies
Study Type: INTERVENTIONAL
Official Title: A Phase 2, Placebo-controlled, Double-blind, Randomized, Dose Ranging, Efficacy and Safety Study of Orally Administered Moxidectin in Adults With Scabies.
Brief Summary:
Moxidectin is not approved to treat scabies in humans.The effective dose of moxidectin to treat scabies is not known.This study aims to assess the efficacy of a single administration of 8 mg, 16 mg, or 32 mg moxidectin per oral in achieving Scabies Complete Cure at Day 28.This study also aims to assess the safety of three strengths of single moxidectin doses in adults with scabies.
Read more